Linked Life Data

19756002

Source:http://linkedlifedata.com/resource/pubmed/id/19756002

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-9-16
pubmed:abstractText
The development of febrile neutropenia during a course of chemotherapy is not only a life-threatening complication, it can also lead to a decision to reduce chemotherapy intensity in subsequent treatment cycles, thus putting patient outcomes at risk. Although there are strategies available for the primary prevention of febrile neutropenia, these are not widely used in the UK management of breast cancer. It is, therefore, paramount to have a well thought out and rigorously implemented care protocol for febrile neutropenia, involving patients, family/carers and health-care professionals in both primary and secondary care, to ensure early detection and effective management.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1532-1827
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
101 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S18-22
pubmed:dateRevised
2010-9-2
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Management of chemotherapy-associated febrile neutropenia.
pubmed:affiliation
NCRN Coordinating Centre, University of Leeds, MacMillan Wing, Fairbairn House, 71-75 Clarendon Road, Leeds LS2 9PH, UK. d.cameron@ncrn.org.uk
pubmed:publicationType
Journal Article